{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T09:07:45Z","timestamp":1777540065995,"version":"3.51.4"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.jchromb.2020.122235","type":"journal-article","created":{"date-parts":[[2020,6,27]],"date-time":"2020-06-27T19:26:18Z","timestamp":1593285978000},"page":"122235","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Quantitation of residual valproic acid in flu vaccine drug substance"],"prefix":"10.1016","volume":"1152","author":[{"given":"Gengcheng","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangchun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanhong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel B.","family":"Gowetski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Q.","family":"Paula Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2020.122235_b0005","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/nm.3927","article-title":"Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection","volume":"21","author":"Yassine","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.jchromb.2020.122235_b0010","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jbiotec.2010.05.003","article-title":"Valproic acid enhances recombinant mRNA and protein levels in transiently transfected Chinese hamster ovary cells","volume":"148","author":"Wulhfard","year":"2010","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.jchromb.2020.122235_b0015","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/bit.21882","article-title":"Valproic acid: a viable alternative to sodium butyrate for enhancing protein expression in mam-malian cell cultures","volume":"101","author":"Backliwal","year":"2008","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.jchromb.2020.122235_b0020","first-page":"629","article-title":"Phamacokenetics of valproic acid after administration of three oral formulations in healthy adults","volume":"38","author":"Bano","year":"1990","journal-title":"J. Assoc. Physicians India"},{"key":"10.1016\/j.jchromb.2020.122235_b0025","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2165\/00023210-200822040-00004","article-title":"Pregnancy outcome after in utero exposure to valproate: evidence of dose relationship in terato-genic effect","volume":"22","author":"Diav-Citrin","year":"2008","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jchromb.2020.122235_b0030","unstructured":"ICH Q3A (R2): Impurities in new drug substances; ICH Q3B (R2): Impurities in new drug products; ICH Q3C(R6) Impurities, guideline for residual solvents; ICH Q6A: Specifications of test procedures and acceptance criteria for new drug substances and new drug products: chemical substances."},{"key":"10.1016\/j.jchromb.2020.122235_b0035","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0009-8981(74)90359-3","article-title":"The use of an automatic solids injection system for quantitative determination of plasma long chain non-esterified fatty acids by gas-liquid chromatography","volume":"53","author":"McDonald-Gibson","year":"1974","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jchromb.2020.122235_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-2275(20)34734-9","article-title":"Long chain nonesterified fatty acid patterns in plasma of healthy children and young adults in re-lation to age and sex","volume":"22","author":"Rogiers","year":"1981","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jchromb.2020.122235_b0045","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0163-7827(88)90003-3","article-title":"Recent advances in the high-performance liquid chromatography of lipids","volume":"27","author":"Shukla","year":"1988","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.jchromb.2020.122235_b0050","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF02276848","article-title":"HPLC Method for the Simultaneous Analysis of Valproic Acid and other Common Anticonvul-sant Drugs in Human Plasma or Serum","volume":"33","author":"Lucarelli","year":"1992","journal-title":"Chromatographia"},{"key":"10.1016\/j.jchromb.2020.122235_b0055","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jchromb.2006.11.027","article-title":"Quantification of valproic acid and its metabolite 2-propyl-4-pentenoic acid in human plasma using HPLC-MS\/MS","volume":"850","author":"Cheng","year":"2006","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jchromb.2020.122235_b0060","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jpha.2015.11.006","article-title":"Liquid chromatography\u2013tandem mass spectrometry method for simultaneous determination of valproic acid and its ene-metabolites in epilepsy patient plasma","volume":"6","author":"Lu","year":"2016","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.jchromb.2020.122235_b0065","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0378-4347(98)00403-4","article-title":"Rapid quantitation of free fatty acids in human plasma by high-performance liquid chromatog-raphy","volume":"719","author":"Mehta","year":"1998","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jchromb.2020.122235_b0070","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1016\/S0021-9258(19)76920-8","article-title":"Microdetermination of long-chain fatty acids in plasma and tissues","volume":"235","author":"Dole","year":"1960","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jchromb.2020.122235_b0075","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1172\/JCI103259","article-title":"A relation between non-esterified fatty acids in plasma and the metabolism of glucose","volume":"35","author":"Dole","year":"1956","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jchromb.2020.122235_b0080","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1093\/clinchem\/39.5.825","article-title":"Fast HPLC determination of serum free fatty acids in the picomole range","volume":"29","author":"P\u00fcttmann","year":"1993","journal-title":"Clin. Chem."},{"issue":"3 Pt 1","key":"10.1016\/j.jchromb.2020.122235_b0085","first-page":"E431","article-title":"Validation of a new method for determination of free fatty acid turnover","volume":"252","author":"Miles","year":"1987","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.jchromb.2020.122235_b0090","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1021\/ac60361a025","article-title":"Phenacyl esters of fatty acid via crown ether catalyst for enhanced ultraviolet detection in liquid chromatography","volume":"47","author":"Durst","year":"1975","journal-title":"Anal. Chem."}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023220305572?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023220305572?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T23:01:59Z","timestamp":1761606119000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023220305572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":18,"alternative-id":["S1570023220305572"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2020.122235","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantitation of residual valproic acid in flu vaccine drug substance","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2020.122235","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"122235"}}